A new protocol for RhD-negative pregnant women?
Can cell-free DNA testing reduce unnecessary use of anti-D immunoglobulin in RhD-negative women and still prevent harm to their RhD-positive infants? PRACTICE CHANGER: Employ cell-free DNA testing at 27 weeks’ gestation in your RhD-negative obstetric patients to reduce unnecessary use of anti-D immunoglobulin.
Journal of Family Practice, 67(5) 2018: 306-319.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.